(Total Views: 97)
Posted On: 02/07/2022 3:11:00 PM
Post# of 74550

$ADMP News Article - Adamis Pharmaceuticals Provides Enrollment Update of Subjects in Phase 2/3 Study of Tempol for the Treatment of COVID-19 https://marketwirenews.com/news-releases/adam...89006.html


My Twitter: WhyteStocks